BEXIMCO PHARMACEUTICALS LTD.
News Release
23 March 2006
Beximco Pharmaceuticals Ltd introduces Osefluto
fight against the Bird Flu
Leading drug manufacturer in Bangladesh Beximco Pharmaceuticals Limited
introduced yesterday (March 22, 2006) Oseflu capsule for the prevention and
treatment of human cases of Avian influenza (H5N1) causing Bird flu.
The capsule contains Oseltamivir 75 mg that ensures outstanding efficacy
against pandemic strains of influenza including reducing the severity and
duration of symptoms and the complications arising from any influenza infection
and mortality.
Due to its safety and effectiveness against pandemic strains of influenza, the
World Health Organization has recommended it in the event of an influenza
pandemic, a senior official of Beximco Pharma said.
Regarding the launching of the drug he said, although no bird flu virus is still
detected in Bangladesh, the country is at the risk of spreading of this virus as it
has been detected in a large volume in India and Myanmar, the neighbouring
countries of Bangladesh.
Meanwhile, different UN agencies expressed concern that Bangladesh might
have devastating consequences of this deadly contiguous disease, he added.
According to the company source, people can easily avoid Bird Flu by following
some simple guidelines in their daily life like eating properly boiled (70 C)
chicken and eggs, washing eggs and chickens before refrigeration, washing
hands, utensils with soaps and warm water, keeping children away from poultry
etc. People should not panic if they suspect to have Bird flu and should talk to
doctors within 48 hours and take proper medicines.
Although Avian influenza or Bird-flu is a contagious disease of animals caused by
viruses that normally infect only birds, it causes death of human beings also
specially people who are engaged with the poultry activities.
The drug is also effective against both Influenza type A and B. So it can be used
for treatment and prophylaxis of both Influenza type A and B.
Beximco Pharma has opened a 24hrs Bird Flu Hotline for doctors to
provide any kind of information on Bird Flu.
Various public awareness campaigns would soon be undertaken by Beximco
Pharma to aware general people about the protection measures and general
health information relating to Bird Flu.
For more information, please contact:
Beximco Pharmaceuticals Limited
+880 2 8619 151
Nazmul Hassan
Libertas Capital
+44 (0)20 7569 9650
Aamir Quraishi / James Patterson
Financial Dynamics +44 (0)20 7831 3113
David Yates About Beximco Pharmaceuticals Limited [LSE: BXP; DSE: BEXPHARMA]
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also undertakes contract manufacturing for GlaxoSmithKline and is about to commence manufacturing for Novartis. The Company operates from a 20 acre site in Dhaka and currently employs over 1800 staff.
The Company's products are sold to retail outlets, medical institutions and other
pharmaceutical manufacturers in Bangladesh, in regional markets such as Pakistan,
Nepal and Myanmar and in other markets overseas, principally in East Africa (including Kenya) and South East Asia (including Singapore).
In the year ended 31 December 2004, the business generated turnover of approximately Taka 2.77 billion or 23.5 million (2003: Taka 2.52 billion or 21.4 million) and profits
after tax of approximately Taka 329.4 million or 2.8 million (2003: Taka 237.8 million or 2.0 million). As at 31 December 2004, BPL's net assets were approximately Taka 5.17 billion or 43.9 million.

Well,it's 21% scrip dividend with reccord date 21st May. Results out next week should be good although the first quater was disappointing. I,ve got a T20 on it anyway.

Good Final Results and 1st quater 2012 looks very good when compared with the disappointing 2011 result. Dividend goes ex monday!

It's time to try the Beximco dabble again. If history repeats itself,there should be news on Monday--- see posts 35,36&37. My T20 is on.

Well its 15%scrip dividend with record date 20th May. Results out about the 15th should be good.

Final results show Pre tax profit up nearly 14% on growth rate of 17.73%. Dividend is confirmed. shares sell for more than 2.5 times the price on the home mkt.
Is nobody interested?

Well here we are again. Only 5% scrip dividend but 10% cash dividend. Still no one interested?

Another year has gone by and I am looking for good results again.Should be out next week.